Treatment of comorbid insomnia and depression :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Cognitive behavioral therapy for depression and insomnia: A double-blind trial comparison

Insomnia and depression Insomnia and depression
Insomnia and depression Insomnia and depression

This 12-week study with a six-month follow-up aimed to ascertain whether combining Cognitive Behavioral Therapy for Insomnia (CBT-I) with Cognitive Behavioral Therapy for Depression (CBT-D), without extending treatment duration, results in greater reductions in both insomnia and depression compared to CBT-D with a placebo insomnia intervention.

See All

Key take away

CBT-I is recommended as the primary treatment for people with both depression and insomnia. Adding psychological depression treatment alongside CBT-I may not be helpful and could be burdensome.

Background

This 12-week study with a six-month follow-up aimed to ascertain whether combining Cognitive Behavioral Therapy for Insomnia (CBT-I) with Cognitive Behavioral Therapy for Depression (CBT-D), without extending treatment duration, results in greater reductions in both insomnia and depression compared to CBT-D with a placebo insomnia intervention.

Method

Employing therapist-guided internet-delivered treatments, this study was carried out in a psychiatric unit. A total of 126 volunteers were detected with major depression and insomnia disorder by physicians. The enrolled subjects were segregated into two groups:

  • Combined treatment group (n=64): Treated with CBT-I + CBT-D
  • Control group (n=62): Treated with CBT-D + Placebo insomnia intervention

The key outcome measures were self-rating scales: the Insomnia Severity Index (ISI) and the Montgomery-Åsberg Depression Rating Scale (MADRS-S).

Result

When compared to the control group, the combined treatment group demonstrated specific effects on insomnia severity (p = 0.007) but did not exhibit greater efficacy in minimizing the severity of depression. In this double-blind, randomized controlled trial, the within-group effect sizes (Cohen's d) at post-treatment and at six months were: MADRS-S 0.97 and 1.12 (combined), 0.88 and 0.89 (control); ISI 1.40 and 1.42 (combined treatment), 0.95 and 1.00 (control).

It was recommended that CBT-I must be prioritized for patients with comorbid insomnia and depression, possibly as the primary treatment choice. The addition of a psychological depression treatment alongside CBT-I might be overly burdensome and may not confer additional benefits.

Conclusion

CBT-I yielded significant specific effects on insomnia severity and outperformed the control intervention in this aspect. However, both treatments showed similar effects on depression severity, indicating that combining CBT-I with CBT-D did not lead to improved depression outcomes when compared to the control intervention.

Source:

Psychotherapy and Psychosomatics

Article:

Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial

Authors:

Blom K et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: